HW
MEDP icon

Hancock Whitney’s Medpace MEDP Stock Holding History

Hancock Whitney’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.8M Buy
9,060
+126
+1% +$58.1K 0.08% 192
2026
Q1 		$3.74M Sell
8,934
-343
-4% -$176K 0.07% 229
2025
Q4 		$5.21M Sell
9,277
-759
-8% -$431K 0.09% 168
2025
Q3 		$5.16M Sell
10,036
-929
-8% -$406K 0.09% 169
2025
Q2 		$3.44M Sell
10,965
-39,241
-78% -$11.8M 0.07% 208
2025
Q1 		$15.3M Buy
50,206
+1,902
+4% +$640K 0.5% 49
2024
Q4 		$16M Buy
48,304
+484
+1% +$164K 0.51% 47
2024
Q3 		$16M Sell
47,820
-87
-0.2% -$33K 0.51% 42
2024
Q2 		$19.7M Sell
47,907
-786
-2% -$311K 0.67% 30
2024
Q1 		$19.7M Buy
48,693
+3,832
+9% +$1.35M 0.68% 30
2023
Q4 		$13.8M Sell
44,861
-461
-1% -$124K 0.51% 44
2023
Q3 		$11M Buy
45,322
+7,673
+20% +$1.96M 0.45% 61
2023
Q2 		$9.04M Sell
37,649
-5,112
-12% -$1.06M 0.36% 73
2023
Q1 		$8.04M Sell
42,761
-2,291
-5% -$474K 0.32% 76
2022
Q4 		$9.57M Sell
45,052
-768
-2% -$153K 0.37% 69
2022
Q3 		$7.2M Buy
45,820
+4,494
+11% +$717K 0.31% 78
2022
Q2 		$6.19M Sell
41,326
-3,322
-7% -$481K 0.25% 84
2022
Q1 		$7.3M Buy
44,648
+31
+0.1% +$5.11K 0.25% 82
2021
Q4 		$9.71M Sell
44,617
-339
-0.8% -$71K 0.31% 75
2021
Q3 		$8.51M Buy
44,956
+39,804
+773% +$7.26M 0.3% 79
2021
Q2 		$910K Sell
5,152
-136
-3% -$23.5K 0.03% 420
2021
Q1 		$867K Sell
5,288
-2,820
-35% -$431K 0.03% 426
2020
Q4 		$1.13M Sell
8,108
-395
-5% -$49.8K 0.04% 367
2020
Q3 		$951K Sell
8,503
-55
-0.6% -$6.36K 0.04% 372
2020
Q2 		$796K Sell
8,558
-2,464
-22% -$210K 0.03% 412
2020
Q1 		$809K Sell
11,022
-6,906
-39% -$600K 0.03% 410
2019
Q4 		$1.51M Sell
17,928
-1,609
-8% -$125K 0.05% 367
2019
Q3 		$1.64M Sell
19,537
-1,933
-9% -$146K 0.05% 336
2019
Q2 		$1.41M Buy
+21,470
New +$1.24M 0.05% 384

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Hancock Whitney's MEDP Position: Q2 2026 in Review

Hancock Whitney increased its Medpace (MEDP) stake by 1.4% in Q2 2026, buying an estimated $58.1K and bringing the position to 9,060 shares worth $4.8M. The position accounts for 0.08% of the portfolio, ranked #192.

Hancock Whitney first reported a position in MEDP in Q2 2019 and has held it in 29 quarters since. The position peaked at $19.7M in Q2 2024. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Hancock Whitney held 9,060 shares of Medpace worth $4.8M as of Q2 2026.
  • Hancock Whitney bought 126 Medpace shares in Q2 2026, an estimated $58.1K.
  • Medpace made up 0.08% of Hancock Whitney's portfolio in Q2 2026, its #192 holding.
  • Hancock Whitney first reported a position in Medpace in Q2 2019 and has held it in 29 quarters since.
  • Hancock Whitney's Medpace position peaked at $19.7M in Q2 2024.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.